Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.numecd.2020.09.004 http://scihub22266oqcxt.onion/10.1016/j.numecd.2020.09.004 33229199!7485447!33229199     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33229199&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Nutr+Metab+Cardiovasc+Dis 2021 ; 31 (1): 2-13 Nephropedia Template TP {{tp|p=33229199|t=2021. Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis |pdf=|usr=}}{{33229199}} gab.com Text Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis JO: Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=33229199 #FOAvip BACKGROUND AND AIMS: Emerging data have linked the presence of cardiac injury with a worse prognosis in novel coronavirus disease 2019 (COVID-19) patients. However, available data cannot clearly characterize the correlation between cardiac injury and COVID-19. Thus, we conducted a meta-analysis of recent studies to 1) explore the prevalence of cardiac injury in different types of COVID-19 patients and 2) evaluate the association between cardiac injury and worse prognosis (severe disease, admission to ICU, and mortality) in patients with COVID-19. METHODS AND RESULTS: Literature search was conducted through PubMed, the Cochrane Library, Embase, and MedRxiv databases. A meta-analysis was performed with Stata 14.0. A fixed-effects model was used if the I(2) values </= 50%, otherwise the random-effects model was performed. The prevalence of cardiac injury was 19% (95% CI: 0.15-0.22, and p < 0.001) in total COVID-19 patients, 36% (95% CI: 0.25-0.47, and p < 0.001) in severe COVID-19 patients, and 48% (95% CI: 0.30-0.66, and p < 0.001) in non-survivors. Furthermore, cardiac injury was found to be associated with a significant increase in the risk of poor outcomes with a pooled effect size (ES) of 8.46 (95% CI: 3.76-19.06, and p = 0.062), severe disease with an ES of 3.54 (95% CI: 2.25-5.58, and p < 0.001), admission to ICU with an ES of 5.03 (95% CI: 2.69-9.39, and p < 0.001), and mortality with an ES of 4.99 (95% CI: 3.38-7.37, and p < 0.001). CONCLUSIONS: The prevalence of cardiac injury was greatly increased in COVID-19 patients, particularly in patients with severe disease and non-survivors. COVID-19 patients with cardiac injury are more likely to be associated with poor outcomes, severity of disease, admission to ICU, and mortality. Twit Text FOAVip Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis ????Nutr Metab Cardiovasc Dis http://www.kidney.de/pget.php?&tw=1&pmid=33229199 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33229199 #FOAvip English Wikipedia <ref>{{Cite pmid|33229199}}</ref> Prevalence and clinical outcomes of cardiac injury in patients with COVID-19: A systematic review and meta-analysis #MMPMID33229199 Huang Z; Huang P; Du B; Kong L; Zhang W; Zhang Y; Dong J Nutr Metab Cardiovasc Dis 2021[Jan]; 31 (1): 2-13 PMID33229199show ga BACKGROUND AND AIMS: Emerging data have linked the presence of cardiac injury with a worse prognosis in novel coronavirus disease 2019 (COVID-19) patients. However, available data cannot clearly characterize the correlation between cardiac injury and COVID-19. Thus, we conducted a meta-analysis of recent studies to 1) explore the prevalence of cardiac injury in different types of COVID-19 patients and 2) evaluate the association between cardiac injury and worse prognosis (severe disease, admission to ICU, and mortality) in patients with COVID-19. METHODS AND RESULTS: Literature search was conducted through PubMed, the Cochrane Library, Embase, and MedRxiv databases. A meta-analysis was performed with Stata 14.0. A fixed-effects model was used if the I(2) values |Adult[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*epidemiology/mortality[MESH] |Female[MESH] |Heart Diseases/*epidemiology/mortality/virology[MESH] |Hospitalization/statistics & numerical data[MESH] |Humans[MESH] |Intensive Care Units/statistics & numerical data[MESH] |Male[MESH] |Middle Aged[MESH] |Prevalence[MESH] |Prognosis[MESH] |SARS-CoV-2[MESH]Prevalence and clinical outcomes of cardiac injury in patients with CO(epmc).pdf DeepDyve Pubget Overpricing